位置:成果数据库 > 期刊 > 期刊详情页
帕金森病发病机制的研究进展
  • ISSN号:1673-9523
  • 期刊名称:《中国现代药物应用》
  • 时间:0
  • 分类:R285.5[医药卫生—中药学;医药卫生—中医学] R971[医药卫生—药品;医药卫生—药学]
  • 作者机构:[1]第四军医大学西京医院中医药研究中心,陕西西安710032, [2]第四军医大学唐都医院神经外科,陕西西安710032, [3]第四军医大学西京医院老年病科,陕西西安710032
  • 相关基金:国家自然科学基金项目(81173590)
中文摘要:

目的:研究红景天苷(Salidroside,Sal)对在MPP+诱导SH-SY5Y细胞线粒体形态和功能的影响及其机制。方法:采用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide,MTT)检测细胞活性,Mito Tracker Red CMXRos进行线粒体染色,四甲基罗丹明乙酯(Tetramethylrhodamine ethyl ester,TMRE)检测线粒体膜电位,Western blot检测PINK1和Parkin蛋白表达水平。结果:单纯Sal处理24 h对细胞活性、线粒体形态和MMP无影响(P〉0.05)。MPP+(500μM)处理SH-SY5Y细胞24 h后,与正常组比较,细胞活性、MMP水平均降低,线粒体长度减短(P〈0.01),并发生碎片化。Sal(25μM)预处理24 h可以显著抑制MPP+诱导的细胞活性降低(P〈0.01),并维持线粒体长度和增加MMP水平(P〈0.01)。而且,Sal(25μM)预处理24 h可以显著恢复MPP+诱导的PINK1和Parkin蛋白表达水平下降(P〈0.01)。结论:体外实验证实Sal可以保护MPP+诱导的SH-SY5Y细胞活性降低、线粒体形态和功能异常,而PINK1-Parkin通路可能是其机制之一,为进一步临床开发Sal治疗PD的新药提供实验依据。

英文摘要:

Objective: This study aims to investigate the mechanism of Salidroside(Sal) protecting mitochondrial morphology and function in MPP+induced SH-SY5 Y cells. Methods: 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide(MTT) assay was used to test the cell activity; Mito Tracker Red CMXRos was used to test the mitochondrial morphology; Tetramethylrhodamine ethyl ester(TMRE) was used to test the mitochondrial membrane potential(MMP) and Western blot method was used to detect the protein level of PINK1 and Parkin. Results: Sal treatment of 24 h had no effect on cell activity, mitochondrial morphology and MMP(P〈0.05). When compared with the control group, the cell activity and MMP levels were statistically decreased respectively(P〈0.01), and the length of mitochondrial was statistically shortened(P〈0.01) and in fragmentation after MPP+(500 μM) treated 24 h in SH-SY5 Y cells. However,pretreatment with Sal(25 μM) 24 h could significantly inhibit MPP+induced the decrease of cellular activity(P〈0.01), and maintain mitochondrial length and increase the level of MMP(P〈0.01). Moreover, pretreatment with Sal(25 μM) 24 h could significantly inhibit the MPP+(500 μM) induced the decrease of protein level of PINK1 and Parkin(P〈0.01). Conclusion: Our vitro experiments showed that Sal could protect the MPP+induced the decrease of SH-SY5 Y cell activity and shortened the length of mitochondrial and in fragmentation.PINK1-Parkin pathway might be one of the mechanisms. It was provided experimental basis for Sal as a new drug for the treatment of PD.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国现代药物应用》
  • 主管单位:中华人民共和国卫生部
  • 主办单位:中国水利电力医学科学技术学会
  • 主编:董占东
  • 地址:北京市和平里七区18号楼205室
  • 邮编:100013
  • 邮箱:xiandai@zgsyyy.cn
  • 电话:010-84254812
  • 国际标准刊号:ISSN:1673-9523
  • 国内统一刊号:ISSN:11-5581/R
  • 邮发代号:80-705
  • 获奖情况:
  • 国内外数据库收录:
  • 被引量:72821